Janus Henderson Group PLC Tarsus Pharmaceuticals, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 512,960 shares of TARS stock, worth $24.6 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
512,960
Previous 12,482
4009.6%
Holding current value
$24.6 Million
Previous $691,000
3713.31%
% of portfolio
0.02%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
210Shares Held
44.2MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$159 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$157 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$125 Million6.87% of portfolio
-
Jennison Associates LLC2.47MShares$118 Million0.06% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$118 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.28B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...